- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06344923
Peritoneum and Anterior Rectus Sheath Suturing and Ileostomy
October 13, 2024 updated by: Qilu Hospital of Shandong University
Does Suturing the Peritoneum and Anterior Rectus Sheath Affect the Safety of Temporary Loop Ileostomy After Laparoscopic Anterior Rectal Resection
In the era of laparoscopy, ileostomy via specimen extraction site has been proposed as a novel approach for temporary ostomy creation to prevent anastomotic leak after laparoscopic low anterior rectal resection.
Whether suturing the layer of the peritoneum and anterior rectus sheath affects the safety of this novel approach has not been investigated.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shandong
-
Jinan, Shandong, China, 250012
- Recruiting
- Qilu Hospital of Shandong University
-
Contact:
- Xiang Zhang
- Phone Number: +8618560089182
- Email: xiang.zhang02@hotmail.com
-
Principal Investigator:
- Xiang Zhang, M.D. Ph.D
-
Sub-Investigator:
- Yanlei Wang, M.D. Ph.D
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- preventive ileostomy in laparoscopic rectal surgery
Exclusion Criteria:
- ileostomy due to anastomotic leak
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: modified preventive ileostomy
Ileostomy with a support rod instead of the layer of peritoneum and anterior rectus sheath suturing
|
The terminal ileum about 30cm proximal to the cecum was recognized and was lifted out of the body through the auxiliary incision at the right lower abdomen and made sure that the ileum was not twisted.
Appropriate sutures can be used to narrow the peritoneal incision, preferably by inserting one finger.
A support rod, made of a 24# silicone drainage tube with a 1ml syringe was passed through the mesentery of the small intestine.
The support rod was removed two weeks after surgery.
It is appropriate that the ileum wall protruded from the epidermis by about 3cm.
After suturing trocar sites, the loop ileostomy was opened along the longitudinal axis of the intestinal wall, and 4-0 absorbable suture was used to fix the stoma and subcutaneous tissue circumferentially with 16-20 stitches.
|
|
Active Comparator: conventional preventive ileostomy
Ileostomy with the layer of the peritoneum and anterior rectus sheath suturing
|
The terminal ileum about 30cm proximal to the cecum was recognized and was lifted out of the body through the auxiliary incision at the right lower abdomen and made sure that the ileum was not twisted.
Appropriate sutures can be used to narrow the peritoneal incision, preferably by inserting one finger.
The seromuscular layer of the ileum or the mesentery was intermittently sutured with peritoneum and the anterior sheath of the rectus abdominis circumferentially with 8-10 stitches (3-0 silk thread).
It is appropriate that the ileum wall protruded from the epidermis by about 3cm.
After suturing trocar sites, the loop ileostomy was opened along the longitudinal axis of the intestinal wall, and 4-0 absorbable suture was used to fix the stoma and subcutaneous tissue circumferentially with 16-20 stitches
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
postoperative complications related to ileostomy
Time Frame: after primary surgery to ileostomy closure (6 months after primary surgery)
|
after primary surgery to ileostomy closure (6 months after primary surgery)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 14, 2024
Primary Completion (Estimated)
May 31, 2025
Study Completion (Estimated)
September 1, 2025
Study Registration Dates
First Submitted
March 24, 2024
First Submitted That Met QC Criteria
March 31, 2024
First Posted (Actual)
April 3, 2024
Study Record Updates
Last Update Posted (Actual)
October 16, 2024
Last Update Submitted That Met QC Criteria
October 13, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KYLL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rectal Neoplasms
-
University of EdinburghNHS LothianNot yet recruitingRectal Cancer | Bowel Cancer | Rectal Adenocarcinoma | Polyp Rectal | Rectal AdenomaUnited Kingdom
-
Jagiellonian UniversityNot yet recruitingRectal Cancer | Rectal Adenocarcinoma | Rectal Adenoma | Recurrent Rectal Adenocarcinoma | Rectal Neuroendocrine NeoplasmPoland
-
Ohio State University Comprehensive Cancer CenterNovartis Pharmaceuticals; National Comprehensive Cancer NetworkCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Recurrent Rectal CancerUnited States
-
Colospan Ltd.RecruitingRectal Cancer | Rectal Tumor | Rectal/AnalUnited States, Israel, Italy
-
SafeHeal IncTerminatedSafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study (SAFE-2)Colorectal Cancer | Rectal Cancer | Rectal Tumor | Rectal/AnalUnited States, France, Belgium
-
Sahlgrenska University HospitalGöteborg UniversityNot yet recruitingRectal Cancer | Rectal Cancer Patients | Rectal Cancer Surgery | Rectal Cancer, RadiotherapySweden
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)WithdrawnStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Rectal AdenocarcinomaUnited States
-
Turkish Society of Colon and Rectal SurgeryBaskent University; Dokuz Eylul University; Halic University; Acibadem Kent Hospital and other collaboratorsNot yet recruitingRectal Cancer Stage II | Rectal Cancer Stage III | Mid-Rectal CancerTurkey
-
University of California, DavisNational Cancer Institute (NCI)Not yet recruitingRectal Cancer | Rectal Adenocarcinoma | Locally Advanced Rectal Adenocarcinoma | Early-stage Rectal CancerUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Taiho Pharmaceutical Co., Ltd.Active, not recruitingStage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage IIA Rectal Cancer AJCC v8 | Stage IIB Rectal Cancer AJCC v8United States